Bio-waiver for Pregabalin Capsules [Dissolution / BCS / IVIVC]

posted by Maitri – India, 2017-11-16 12:41 (1959 d 19:37 ago) – Posting: # 17984
Views: 5,704

❝ In few cases FDA has not at all accepted the published literature information (even the Clinical Pharmacology and biopharmaceutics data of Inovator) so one need to be very cautious about that.

Dear luvblooms,

Can you just mentioned the few probable reasons for not accepting the published literature information? If the Clinical Pharmacology and biopharmaceutics data of Innovator clearly demonstrated a validated permeability study conducted using all the standards (low permeable, moderate permeable, high permeable, zero permeable) will it be acceptable in your opinion? :confused:

Thank You in advance! :-)

Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5! [Helmut]

Complete thread:

UA Flag
 Admin contact
22,557 posts in 4,724 threads, 1,608 registered users;
22 visitors (0 registered, 22 guests [including 7 identified bots]).
Forum time: 09:19 CEST (Europe/Vienna)

A scientist’s aim in a discussion with his colleagues
is not to persuade, but to clarify.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz